Over at In the Pipeline, Derek Lowe makes an analogy, comparing the movie business to big pharma. The similarities, he writes, are that both incur most of their costs in R&D and marketing spending and blockbusters are hard to predict. The differences are that the barrier to entry is a lot higher for distributing new drugs and movies can make money longer than patented drugs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.